Peter B. Berger
Impact in
- Cardiology and Cardiovascular Medicine top 0.05%
- Antiplatelet Therapy and Cardiovascular Diseases
- Acute Myocardial Infarction Research
- Cardiac, Anesthesia and Surgical Outcomes
- Atrial Fibrillation Management and Outcomes
- Surgery top 0.1%
- Coronary Interventions and Diagnostics
- Lipoproteins and Cardiovascular Health
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 140
- Acute Myocardial Infarction Research 79
- Atrial Fibrillation Management and Outcomes 14
- Surgery 160
- Coronary Interventions and Diagnostics 149
- Cardiac and Coronary Surgery Techniques 7
- Co-authors
- Eric J. Topol (41 shared papers)David R. Holmes (91 shared papers)Steven R. Steinhubl (34 shared papers)Malcolm Rice Bell (47 shared papers)Ryan J. Lennon (24 shared papers)Deepak L. Bhatt (26 shared papers)Charanjit S. Rihal (23 shared papers)Patricia J.M. Best (16 shared papers)
- Journals
- Journal of the American College of Cardiology (76 papers)The American Journal of Cardiology (38 papers)Circulation (38 papers)American Heart Journal (38 papers)Catheterization and Cardiovascular Interventions (19 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Peter B. Berger
391 papers receiving 30.8k citations
Peter B. Berger's Hit Papers
Peers
Comparison fields: 5 of 150
- Cardiology and Cardiovascular Medicine 18k
- Surgery 9k
- Nephrology 2k
- Internal Medicine 422
- Hematology 1.1k
Countries citing papers authored by Peter B. Berger
This map shows the geographic impact of Peter B. Berger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter B. Berger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter B. Berger more than expected).
Fields of papers citing papers by Peter B. Berger
This network shows the impact of papers produced by Peter B. Berger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter B. Berger. The network helps show where Peter B. Berger may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter B. Berger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 398 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention Hit paper breakdown → | 2002 | 2458 |
| 2 | Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events Hit paper breakdown → | 2006 | 2141 |
| 3 | Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention Hit paper breakdown → | 2002 | 1418 |
| 4 | Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden Hit paper breakdown → | 2008 | 1233 |
| 5 | ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary Hit paper breakdown → | 2002 | 1139 |
| 6 | Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta‐analysis Hit paper breakdown → | 2009 | 851 |
| 7 | Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease Hit paper breakdown → | 2005 | 668 |
| 8 | Variability in platelet responsiveness to clopidogrel among 544 individuals Hit paper breakdown → | 2005 | 650 |
| 9 | The Perioperative Management of Antithrombotic Therapy Hit paper breakdown → | 2008 | 644 |
| 10 | The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions Hit paper breakdown → | 2002 | 628 |
| 11 | Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial Hit paper breakdown → | 2007 | 622 |
| 12 | Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study Hit paper breakdown → | 2013 | 491 |
| 13 | 2004 | 482 | |
| 14 | 1999 | 474 | |
| 15 | 2004 | 417 | |
| 16 | 2008 | 398 | |
| 17 | 2011 | 351 | |
| 18 | 2003 | 329 | |
| 19 | 2010 | 301 | |
| 20 | 2005 | 289 |
About Peter B. Berger
Peter B. Berger is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Health Information Management, Nephrology and Hematology, having authored 398 papers that have together received 33.8k indexed citations. Recurring topics across this work include Coronary Interventions and Diagnostics (149 papers), Antiplatelet Therapy and Cardiovascular Diseases (140 papers), Acute Myocardial Infarction Research (79 papers), Atrial Fibrillation Management and Outcomes (14 papers), Mechanical Circulatory Support Devices (11 papers), Vascular Procedures and Complications (8 papers), Cardiac and Coronary Surgery Techniques (7 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (18k citations), Surgery (9k citations), Nephrology (2k citations), Internal Medicine (422 citations) and Hematology (1.1k citations). Peter B. Berger has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Eric J. Topol, David R. Holmes, Steven R. Steinhubl, Malcolm Rice Bell, Ryan J. Lennon, Deepak L. Bhatt, Charanjit S. Rihal, Patricia J.M. Best, Emmanouil S. Brilakis and Edward T.A. Fry. Their work appears in journals such as Journal of the American College of Cardiology, The American Journal of Cardiology, Circulation, American Heart Journal and Catheterization and Cardiovascular Interventions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.